UJI SENSITIVITAS MYCOBACTERIUM TUBERCULOSIS TERHADAP OBAT ANTI TUBERKULOSIS PADA PENDERITA TUBERKULOSIS PARU DENGAN DIABETES MELITUS
Abstract
Diabetes mellitus is a chronic disease marked with high blood sugar levels. Patients with diabetes mellitus susceptible to pulmonary tuberculosismaking it difficult for to cure them. This research aims to find out figure of anti tuberculosis drug resistance in patients with pulmonary tuberculosis with diabetes mellitus. This descriptive research was conducted in the Laboratory of Microbiology Center for Lung Disease Treatment Lubuk Alung West Sumatra. Sputum samples were pulmonary tuberculosis patients with diabetes mellitus as many as 10 samples. The results of Mycobacterium tuberculosis sensitivity to anti-tuberculosis drugs in patients with pulmonary tuberculosis with diabetes mellitus showed resistance to one drug, isoniazid by 10% and the other anti tuberculosis drugs are not resistance.
Key words : diabetes mellitus, pulmonary tuberculosis, anti tuberculosis drugs, resistanceFull Text:
PDF (Bahasa Indonesia)References
Aditama, T.Y dan Luthni E. 2009. Buku Petunjuk Teknik Pemeriksaan Laboratorium Tuberkulosis Edisi II. Jakarta
Aditama T.Y. 2004. Mott dan Multidrug Resistens. J Resp Ind, 42:157
Amin, Z dan Bahar A. 2006. Tuberkulosis Paru Dalam Buku Ajar Ilmu Penyakit Dalam Jilid II Edisi V. Jakarta; FKUI
Bashar M, Alcabes P, dan Rom W.N. 2001. Increased Incidence Of Multidrug Resistant Tuberculosis In Diabetic. Jakarta : ECG
Depkes RI. 2007. Pedoman Penanggulangan Tuberkulosis Edisi 2. Cetakan Kedua. Jakarta Depkes RI
Depkes RI. 2008. Pedoman Penaggulangan Tuberkulosis Edisi 2. Cetakan Kedua. Jakarta Depkes RI
Dinas Kesehatan Provinsi Sumatera Barat. 2009. Profil Kesehatan Provinsi Sumatera Barat. Website: http//www.dinkes-sumbar.org
Fordiastiko. 1995. Penatalaksanaan Tuberkulosis Paru Pada Penderita Diabetes Melitus. Majalah paru
Guptan, A dan Ashok S. 2000. Tuberculosis and Diabetes Melitus An Appraisal. Indian Journal of Tuberculosis. 5 (2). http//www.medind.nic.in
Mansyur. 2001. The Pattern Of Antituberculosis Drug Resistenin Pulmonary Tuberculosis Pattient. Journal Respirologi Indonesia. 21: 24-27.
Masniari L, T.Y Aditama , dan W.H Wiyono . 2005. Penilaian Hasil Pengobatan Tb Paru dan Faktor-Faktor yang Mempengaruhi serta Alasan Berobat di RS Persahabatan Jakarta. J Respir Indo. 27 (3)
Nikmawati, Windarwati, dan Hardjoeno. 2006. Resistensi Mycobacterium tuberkulosis terhadap Obat Anti Tuberkulosis. Indonesian Journal of Clinical Pathology and Medical Laboratory. 12 (2): 58-61
Robert J, Trystram D, Pernot C.T. 2003. Multidrug Resistant Tuberculosis. Prancis: EGC
Simion S. 2007. Multidrug Resistence (MDR) Pada Penderita Tuberkulosis Paru Dengan Diabetes Melitus. Tesis. Fakultas Kedokteran Universitas Negeri Sumatera Utara.
Suradi, J dan Surjanto. 2004. Diabetes Melitus dan Tuberkulosis Paru. Makalah disampaikan dalam simposium diabetes melitus. Semarang 15 Juli 2004
Syafril, S. 1996. Konsesus Pengelolahan Diabetes Melilitus Indonesia. Makalah Disampaikan Dalam Simposium Diabetes Melitus Dan Penyakit Degeneratif. Padang 19 Oktober 1996.
Tim Gerakan Terpadu Nasional Penaggulangan Tuberkulosis (GEDURNAS – TB). 2007. Pedoman Nasional Penanggulangan Tuberkulosis. Jakarta: Depkes.
UPTD Balai Pengobatan Penyakit Paru (BP4). 2010. Laporan Kegiatan Balai Pengobatan Penyakit Paru (BP4). Lubuk Alung, Sumatera Barat.
Warta GEDURNAS TB. 2010. Buletin Triwulan Warta GEDURNAS TB. Volume 16. Februari 2010. Jakarta
Wibowo, S. 1990. Pengobatan Tuberkulosis Paru. Cermin Dunia Kedokteran: 50-52
DOI: http://dx.doi.org/10.31958/js.v7i1.125
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Elsa Yuniarti
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Indexed by:
__________________________________________________________________________
Sainstek: Jurnal Sains dan Teknologi
ISSN 2085-8019 (print) | 2580-278x (online)
Published by Institut Agama Islam Negeri Batusangkar
Email: sainstek@iainbatusangkar.ac.id
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.